DOCSLIB.ORG

Small Cell Tumors, Lymphomas, and Sertoli Cell and Leydig Cell Tumors of the Bladder, Prostate, and Testis Chris M

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Small Cell Tumors, Lymphomas, and Sertoli Cell and Leydig Cell Tumors of the Bladder, Prostate, and Testis Chris M 26 Small Cell Tumors, Lymphomas, and Sertoli Cell and Leydig Cell Tumors of the Bladder, Prostate, and Testis Chris M. Bacon and Alex Freeman Lymphomas of the Testis, pathological features, therapeutic needs, and prognoses, and all require specialist manage- Bladder, and Prostate ment. Another major determinant of treatment choice and outcome is the stage of lymphoma at Approximately one third of lymphomas arise presentation. In this regard, lymphomas of the at an extranodal site (primary extranodal lym- genitourinary tract are, like lymphomas arising phomas), and both primary nodal lymphomas elsewhere, staged according to the Ann Arbor and leukemias not infrequently infiltrate extran- staging system. odal tissues secondarily during their course. The genitourinary tract is the site of less than 5% Lymphoma of the Testis of primary extranodal lymphomas [1]. Among these the testis is the most frequent site. Post- Clinically apparent lymphoma of the testis is mortem studies indicate that the genitourinary rare, representing only approximately 1% of all tract is secondarily involved by lymphoid neo- lymphomas and 5% of all testicular tumors [4,5]. plasms in up to 50% of patients, and such invol- Unlike germ cell tumors, testicular lymphoma vement may be clinically apparent in up to 10% typically occurs in older patients, being the com- of patients [2]. monest testicular neoplasm in men over 60 years Lymphoid neoplasms are currently classified of age [4]. Lymphoma may arise primarily in the according to the World Health Organization testis, or may manifest in the testis secondarily (WHO) Classification of Tumors of the (albeit often early) during the course of systemic Hematopoietic and Lymphoid tissues [3]. In disease. It may sometimes be impossible to dis- this globally accepted classification, devised tinguish these scenarios, even in patients with by an international panel of pathologists, hema- limited (stage I/II) disease, but in most studies tologists, and oncologists, lymphomas and primary testicular lymphoma is defined prag- leukemias are categorized into discrete entities matically as that in which a testicular mass was according to morphological, immunohistologi- the predominant site of clinical disease at pres- cal, genetic, and clinical features. Although some entation [6–9]. There are no established predis- lymphomas are defined by their sites of origin, posing factors for the development of testicular there are no lymphoid neoplasms that arise only lymphoma, although there is an increased inci- in the genitourinary tract. In the clinical setting, dence among men infected with HIV [4]. the correct identification and then subclassi- The majority (approximately 80% to 90%) of fication of lymphoid neoplasms by urologists primary testicular lymphomas are diffuse large and urological pathologists is crucial, as many B cell lymphomas (DLBCLs) [10–13]. Other sub- of the entities defined have distinctive clinico- types, including mature T/natural killer (NK) 309 310 Urological Cancers: Science and Treatment cell lymphomas, follicular lymphomas, Burkitt large,with vesicular nuclei and prominent nucle- lymphomas, and plasma cell neoplasms, are rare oli, although there is variation in morphology primary testicular tumors. Most non-Hodgkin between cases [3]. They express pan–B-cell anti- lymphomas may secondarily involve the testis, gens such as CD20, and many express detectable as may chronic lymphocytic leukemia (CLL) immunoglobulin. In most cases, lymphoma cells and precursor B- or T-cell acute lymphoblastic express the antiapoptotic protein Bcl-2, and a leukemia (ALL), the latter especially in children. high proportion of cells (>40%) express the cell Involvement of the testis by classical Hodgkin cycle protein Ki67, indicating that they are in cell lymphoma is exceptional. These different types cycle. Similar to nodal DLBCL [14], the germinal of lymphoproliferative disorder are biologically center–associated proteins Bcl-6 and CD10 are and clinically distinct, and are thus considered expressed by approximately 80% and 50% of separately below. testicular DLBCL, respectively (unpublished observations). Testicular Diffuse Large B Cell Lymphoma Biology and Genetics Clinical Features Although relatively few studies have specifically Testicular DLBCL typically presents with unilat- examined the biomolecular features of testi- eral painless scrotal swelling in men whose cular DLBCL, available evidence suggests that median age is 60 to 70 years [6–9,12]. Both testes the pathobiology of testicular DLBCL is similar are involved at presentation in up to 15% of in many ways to DLBCL arising elsewhere. patients [6–8], and 5% to 15% present with sys- Both primary testicular DLBCL and DLBCL temic (“B”) symptoms [6–9,13]. Approximately in general are clonal proliferations of mature 50% of patients present with stage I disease B cells whose immunoglobulin genes have (testes only), 20% with stage II disease (regional undergone VDJ (variable-diversity-joining lymph node involvement), 5% with stage III region) rearrangement and, in most cases, disease, and 25% with stage IV disease (dissem- somatic hypermutation [15,16]. Because the inated) [6–8,12]. Characteristic sites of distant latter is a mechanism for diversification of organ involvement include the central nervous immunoglobulin genes that occurs during system (CNS) (especially), Waldeyer’s ring, skin, the germinal center reaction of an immune bone and bone marrow, kidneys, adrenal glands, response, it is believed that DLBCLs arise from and lungs [4,6–8]. Compared to nodal DLBCL, germinal center or postgerminal center B cells. testicular lymphoma is associated with presen- Hyland et al. [15] showed that testicular DLBCLs tation at an earlier stage and a greater propen- display ongoing somatic hypermutation, clonal sity for spread to other extranodal sites. diversification, and a pattern of immunoglo- Pathology bulin gene mutation suggestive of a role for ongoing antigen selection in the evolution of Macroscopically, testicular DLBCL usually forms the lymphoma [15]. Pasqualucci et al. [17] de- an ill-defined, firm or soft, gray, tan, or pink monstrated that more than half of DLBCLs mass, sometimes with areas of hemorrhage or show aberrant somatic hypermutation activity necrosis [4,10]. The lymphoma extends into resulting in mutation of several known proto- paratesticular structures in up to 50% of cases. oncogenes, including MYC [17]. Thus, aberrant Microscopically, a diffuse infiltrate of atypical hypermutation may contribute to genomic lymphoid cells dissects between seminiferous instability in DLBCLs. tubules, or sometimes effaces testicular architec- There is now considerable evidence that ture (Fig 26.1). In many cases lymphoma cells DLBCL is both biologically and clinically het- show at least focal intratubular growth, and erogeneous. In landmark studies, Alizadeh et al. tubules often show suppressed spermatogenesis, [18] and Rosenwald et al. [19] performed large- or atrophy. Interstitial sclerosis is present in scale DNA microarray-based gene expression a third of cases [4,10,11]. Testicular DLBCL analyses of DLBCLs and demonstrated that is cytologically and immunophenotypically DLBCLs showed diverse gene expression pat- similar to DLBCL arising in lymph nodes. The terns, but could be divided into subgroups with neoplastic cells are typically medium-sized to germinal center B-cell–like profiles, in vitro 311 Small Cell Tumors and Tumors of the Bladder, Prostate, and Testis Fig. 26.1. A diffuse large B-cell lymphoma of the testis (A, H&E) showing positive immunohistochemical staining for CD20 (B), Bcl-2 (C) and nuclear BCL-6 (D). Original magnification: A, 100¥; B–D, 200¥. activated B-cell–like profiles, or poorly defined genes were used to successfully formulate prog- heterogeneous type 3 gene expression profiles. nostic algorithms or outcome predictors for Interestingly, these subgroups showed differ- DLBCLs [19,20]. ences in biochemistry and genetics (see below) Several studies have used immunohistochem- and in clinical outcome. Patients whose tumors istry to subclassify DLBCLs into those with a had germinal center B-cell–like gene expression germinal center cell phenotype and those with a profiles had a significantly better 5-year overall postgerminal center cell phenotype according to survival than those whose tumors did not. Two the presence or absence of proteins expressed studies have used DNA microarray technology predominantly by germinal center B cells (Bcl-6 to identify genes whose expression correlates and CD10) or postgerminal center B cells (IRF- with the outcome of DLBCL [19,20]. Many of the 4/MUM-1) [21–24]. Some of these studies have genes implicated are associated with cell prolif- shown germinal center–type protein expression eration, apoptosis, B-cell receptor signaling, to be associated with a favorable overall survival germinal center B-cell phenotype, or lymph [21,23,24], whereas others have failed to demon- node stromal and immune cells, or are major strate any significance [21,22]. histocompatibility complex (MHC) class II Although many DLBCLs exhibit complex genes, highlighting the importance of both cytogenetic abnormalities, several recurrent intrinsic properties of the lymphoma cells genetic alterations have been identified. In 15% and host–tumor interactions in the behavior of to 30% of cases, the BCL2 gene is translocated to DLBCLs. Some of the differentially expressed the immunoglobulin heavy chain gene locus 312 Urological Cancers: Science and Treatment as a result
Load more

Recommended publications
  • Huge Ovarian Sertoli-Leydig Cell Tumor- a Rare Presentation Mimicking Advanced Ovarian Carcinoma: a Clinical Diagnostic Pitfall
    International Journal of Health Sciences and Research Vol.10; Issue: 5; May 2020 Website: www.ijhsr.org Case Report ISSN: 2249-9571 Huge Ovarian Sertoli-Leydig Cell Tumor- A Rare Presentation Mimicking Advanced Ovarian Carcinoma: A Clinical Diagnostic Pitfall Ikeanyi M Eugene1, Udoye P Ezenwa2, Jeremiah Israel1 1Department of Obstetrics and Gynecology, Niger Delta University Teaching Hospital, Okolobiri Bayelsa State Nigeria 2Department of Pathology, Niger Delta University Teaching Hospital, Okolobiri Bayelsa State Nigeria Corresponding Author: Ikeanyi M Eugene ABSTRACT Sertoli-Leydig cell tumor is a very rare ovarian tumor constituting less than 0.5% of all primary ovarian tumors. It mostly occurs in second and third decades of life. This is a case report of a rare presentation of a huge ovarian Sertoli-Leydig cell tumor presenting like an advanced ovarian cancer in a 62 year old seven years postmenopausal para eight woman. At surgery was a left well encapsulated multilobulated ovarian tumour measuring 28 x28x14cm, weighing 6.2kg and histologically containing clusters of Leydig cells and solid cords of Sertoli cells of intermediate differentiation. The patient presented with a year history of progressive abdominal swelling and irregular vaginal bleeding. She had total abdominal hysterectomy and bilateral salpingo-oophorectomy. About a year on follow- up and stable. Keywords: Sertoli-Leydig cell, sex cord, stromal, ovarian, tumor, postmenopausal, neoplasm INTRODUCTION but rarely in any age. It can contain Ovarian Sertoli-Leydig cell tumor is heterologous elements and be functionally one of the categories of sex cord-stromal diverse. It contains testicular structures that tumors of ovary; defined by World Health secrete androgen with varying degrees of Organization (WHO) as groups of tumors virilization based on the quantity of secreted composed of granulosa cells, theca cells, androgen.
    [Show full text]
  • Vocabulario De Morfoloxía, Anatomía E Citoloxía Veterinaria
    Vocabulario de Morfoloxía, anatomía e citoloxía veterinaria (galego-español-inglés) Servizo de Normalización Lingüística Universidade de Santiago de Compostela COLECCIÓN VOCABULARIOS TEMÁTICOS N.º 4 SERVIZO DE NORMALIZACIÓN LINGÜÍSTICA Vocabulario de Morfoloxía, anatomía e citoloxía veterinaria (galego-español-inglés) 2008 UNIVERSIDADE DE SANTIAGO DE COMPOSTELA VOCABULARIO de morfoloxía, anatomía e citoloxía veterinaria : (galego-español- inglés) / coordinador Xusto A. Rodríguez Río, Servizo de Normalización Lingüística ; autores Matilde Lombardero Fernández ... [et al.]. – Santiago de Compostela : Universidade de Santiago de Compostela, Servizo de Publicacións e Intercambio Científico, 2008. – 369 p. ; 21 cm. – (Vocabularios temáticos ; 4). - D.L. C 2458-2008. – ISBN 978-84-9887-018-3 1.Medicina �������������������������������������������������������������������������veterinaria-Diccionarios�������������������������������������������������. 2.Galego (Lingua)-Glosarios, vocabularios, etc. políglotas. I.Lombardero Fernández, Matilde. II.Rodríguez Rio, Xusto A. coord. III. Universidade de Santiago de Compostela. Servizo de Normalización Lingüística, coord. IV.Universidade de Santiago de Compostela. Servizo de Publicacións e Intercambio Científico, ed. V.Serie. 591.4(038)=699=60=20 Coordinador Xusto A. Rodríguez Río (Área de Terminoloxía. Servizo de Normalización Lingüística. Universidade de Santiago de Compostela) Autoras/res Matilde Lombardero Fernández (doutora en Veterinaria e profesora do Departamento de Anatomía e Produción Animal.
    [Show full text]
  • Pinto Mariaetelvina D.Pdf
    i ii iii Dedico À minha família Meu porto seguro... iv Agradecimentos À professora Dra. Rejane Maira Góes, pela sua orientação, ética e confiança. Obrigada por ter contribuído imensamente para o meu amadurecimento profissional e pessoal. Ao professor Dr. Sebastião Roberto Taboga pela sua atenção e auxílio durante a realização deste trabalho. Aos professores: Dr. Luis Antonio Violin Dias Pereira, Dra. Maria Tercilia Vilela de Azeredo Oliveira e Dra. Mary Anne Heidi Dolder pelo cuidado e atenção na análise prévia da tese e pelas valiosas sugestões. Aos professores: Dra. Maria Tercília Vilela de Azeredo Oliveira, Dr. Marcelo Emílio Beletti, Dra. Cristina Pontes Vicente e Dra. Wilma De Grava kempinas pela atenção dispensada e sugestões para o aprimoramento deste trabalho. Ao Programa de Pós-graduação em Biologia Celular e Estrutural e a todos os docentes que dele participa, principalmente àqueles que batalham para que esse curso seja reconhecido como um dos melhores do país. v A secretária Líliam Alves Senne Panagio, pela presteza, eficiência e auxílio concedido durantes esses anos de UNICAMP, principalmente nos momentos de mais correria. À Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – CAPES, pelo imprescindível suporte financeiro. Ao Instituto de Biociências, Letras e Ciências Exatas de São José do Rio Preto, IBILCE-UNESP, por ter disponibilizado espaço físico para a realização da parte experimental deste trabalho. Ao técnico Luiz Roberto Falleiros Júnior do Laboratório de Microscopia e Microanálise, IBILCE-UNESP, pela assistência técnica e amizade. Aos amigos do Laboratório de Microscopia e Microanálise, IBILCE- UNESP: Fernanda Alcântara, Lara Corradi, Sérgio de Oliveira, Bianca Gonçalves, Ana Paula Perez, Manoel Biancardi, Marina Gobbo, Cíntia Puga, Fanny Arcolino, Flávia Cabral e Samanta Maeda, e todos que por ali passaram durante todos esses anos.
    [Show full text]
  • Use of Novel Serum Markers in Clinical Follow-Up of Sertoli-Leydig Cell Tumours
    CORE Metadata, citation and similar papers at core.ac.uk Article in press - uncorrected proof Provided by Open Access LMU Clin Chem Lab Med 2007;45(5):657–661 ᮊ 2007 by Walter de Gruyter • Berlin • New York. DOI 10.1515/CCLM.2007.120 2006/514 Short Communication Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours Miriam Lenhard1,*, Caroline Kuemper1, Nina Keywords: ovarian malignancy; Sertoli-Leydig cell Ditsch1, Joachim Diebold2, Petra Stieber3, tumour; serum marker; sex-cord stromal tumour. Klaus Friese1 and Alexander Burges1 1 Department of Obstetrics and Gynaecology, Sertoli-Leydig cell tumours are classified as sex-cord Campus Grosshadern, Ludwig-Maximilians- stromal tumours. They account for only 0.2% of University, Munich, Germany malignant ovarian tumours and are often found uni- 2 Department of Pathology, Ludwig-Maximilians- laterally (1). Synonyms in the literature are arrheno- University, Munich, Germany blastoma, androblastoma and gonadal stromal 3 Department of Clinical Chemistry, Ludwig- tumour of the android type. Most of these tumours Maximilians-University, Munich, Germany are described in young adults and less than 10% occur prior to menarche or after menopause (2). Two- thirds of all patients are diagnosed with this rare dis- Abstract ease due to the tumour’s hormone production (3). A 41-year-old patient (IV gravida, IV para) presented Background: Sertoli-Leydig cell tumours of the ovary with dyspnoea, enlarged abdominal girth and mela- account for only 0.2% of malignant ovarian tumours. ena. On physical examination, the abdomen was dis- Two-thirds of all patients become apparent due to the tended with a fluid wave.
    [Show full text]
  • Male Reproductive System
    MALE REPRODUCTIVE SYSTEM DR RAJARSHI ASH M.B.B.S.(CAL); D.O.(EYE) ; M.D.-PGT(2ND YEAR) DEPARTMENT OF PHYSIOLOGY CALCUTTA NATIONAL MEDICAL COLLEGE PARTS OF MALE REPRODUCTIVE SYSTEM A. Gonads – Two ovoid testes present in scrotal sac, out side the abdominal cavity B. Accessory sex organs - epididymis, vas deferens, seminal vesicles, ejaculatory ducts, prostate gland and bulbo-urethral glands C. External genitalia – penis and scrotum ANATOMY OF MALE INTERNAL GENITALIA AND ACCESSORY SEX ORGANS SEMINIFEROUS TUBULE Two principal cell types in seminiferous tubule Sertoli cell Germ cell INTERACTION BETWEEN SERTOLI CELLS AND SPERM BLOOD- TESTIS BARRIER • Blood – testis barrier protects germ cells in seminiferous tubules from harmful elements in blood. • The blood- testis barrier prevents entry of antigenic substances from the developing germ cells into circulation. • High local concentration of androgen, inositol, glutamic acid, aspartic acid can be maintained in the lumen of seminiferous tubule without difficulty. • Blood- testis barrier maintains higher osmolality of luminal content of seminiferous tubules. FUNCTIONS OF SERTOLI CELLS 1.Germ cell development 2.Phagocytosis 3.Nourishment and growth of spermatids 4.Formation of tubular fluid 5.Support spermiation 6.FSH and testosterone sensitivity 7.Endocrine functions of sertoli cells i)Inhibin ii)Activin iii)Follistatin iv)MIS v)Estrogen 8.Sertoli cell secretes ‘Androgen binding protein’(ABP) and H-Y antigen. 9.Sertoli cell contributes formation of blood testis barrier. LEYDIG CELL • Leydig cells are present near the capillaries in the interstitial space between seminiferous tubules. • They are rich in mitochondria & endoplasmic reticulum. • Leydig cells secrete testosterone,DHEA & Androstenedione. • The activity of leydig cell is different in different phases of life.
    [Show full text]
  • LEYDIG CELLS AS a MODEL of MALE REPRODUCTIVE SYSTEM Tomáš Jambor*1, Eva Tvrdá1, Jana Lukáčová1, Norbert Lukáč1
    LEYDIG CELLS AS A MODEL OF MALE REPRODUCTIVE SYSTEM Tomáš Jambor*1, Eva Tvrdá1, Jana Lukáčová1, Norbert Lukáč1 Address(es): Ing. Tomáš Jambor, 1Slovak University of Agriculture, Faculty of Biotechnology and Food Sciences, Department of Animal Physiology, Trieda A. Hlinku 2, 949 76 Nitra, Slovak Republic, phone number: +421-37-6414288. *Corresponding author: [email protected] ARTICLE INFO ABSTRACT Received 25. 10. 2013 During the past decades, a large anount of information concerning the infertility, which can be caused by malfunction at the level of Revised 20. 11. 2013 sperm or production of testosterone was published. It is about androgene which is from 95 percent synthetized in testes. It plays Accepted 16. 12. 2013 significant role in development of individual´s sexual signs and is also the starter of spermatogenesis. The main mechanism ensuring the Published 1. 2. 2014 production of this important hormone is the process determined as a steroidogenesis. This process runs in cells located in testes and are known as Leydig cells (LC). Several types of LC are classified as for example fetal, adult, stem, progenitor or immature cells. There are mutual differences, but their common feature is a production of androgenes. Mitochondria and endoplasmic reticulum have irreplaceable Review position within LC and they, together with relevant enzymes and cascades of reactions, ensure the metamorphosis of cholesterol up to testosterone. With rising age the activity of steroidogenesis declines what is, however, natural. But there are many cases when this process in cells of developing individual is impaired by external or internal factors. Their identification and consequent elimination is for sufficient production of testosterone very important.
    [Show full text]
  • Fatal Haemorrhage and Neoplastic Thrombosis in a Captive African Lion
    Gonzales‑Viera et al. Acta Vet Scand (2017) 59:69 DOI 10.1186/s13028-017-0337-5 Acta Veterinaria Scandinavica CASE REPORT Open Access Fatal haemorrhage and neoplastic thrombosis in a captive African lion (Panthera leo) with metastatic testicular sex cord–stromal tumour Omar Antonio Gonzales‑Viera1,2, Angélica María Sánchez‑Sarmiento1* , Natália Coelho Couto de Azevedo Fernandes3, Juliana Mariotti Guerra3, Rodrigo Albergaria Ressio3 and José Luiz Catão‑Dias1 Abstract Background: The study of neoplasia in wildlife species contributes to the understanding of cancer biology, manage‑ ment practices, and comparative pathology. Higher frequencies of neoplasms among captive non-domestic felids have been reported most commonly in aging individuals. However, testicular tumours have rarely been reported. This report describes a metastatic testicular sex cord–stromal tumour leading to fatal haemorrhage and thrombosis in a captive African lion (Panthera leo). Case presentation: During necropsy of a 16-year-old male African lion, the left testicle and spermatic cord were found to be intra-abdominal (cryptorchid), semi-hard and grossly enlarged with multiple pale-yellow masses. Encap‑ sulated haemorrhage was present in the retroperitoneum around the kidneys. Neoplastic thrombosis was found at the renal veins opening into the caudal vena cava. Metastases were observed in the lungs and mediastinal lymph nodes. Histology revealed a poorly diferentiated pleomorphic neoplasm comprised of round to polygonal cells and scattered spindle cells with eosinophilic cytoplasm. An immunohistochemistry panel of inhibin-α, Ki-67, human placental alkaline phosphatase, cytokeratin AE1/AE3, cKit, vimentin and S100 was conducted. Positive cytoplasmic immunolabeling was obtained for vimentin and S100. Conclusions: The gross, microscopic and immunohistochemical fndings of the neoplasm were compatible with a poorly diferentiated pleomorphic sex cord–stromal tumour.
    [Show full text]
  • WHO 2016 Classification of Tumours of the Testis
    WHO 2016 classification of tumours of the testis Dan Berney BAUP/BDIAP 2015 WHO Zurich March 2015 Nomenclature precursor Germ Cell Tumour (GCT) testis CIS IGCNU TIN • CIS – Not a carcinoma • TIN – Not intraepithelial • IGCNU – Unclassified/Undifferentiated… – The spermatogonial niche PLAP CIS IGCNU IGCNU IGCN GCNI GCNIS GCNIS GERM CELL NEOPLASIA IN SITU WHO 2016 Germ cell tumours • Tumours derived from GCNIS of one type • Seminoma • Embryonal carcinoma • Yolk Sac Tumour, post pubertal type • Trophoblastic tumours • Teratoma, post pubertal type • Teratoma with somatic type malignancy Seminoma hCG I am not a choriocarcinoma OCT3/4 Anaplastic seminoma? • ‘Differentiation’ of seminomas • Mitotic rate • Lymphocytic infiltrate • Cell morphology Embryonal carcinoma Hepatoid YST Glandular YST Parietal Solid YST Trophoblastic tumours • Choriocarcioma • Non-choriocarcinomatous trophoblastic tumours – Placental site trophoblastic tumour – Epithelioid trophoblastic tumour – Cystic trophoblastic tumour Choriocarcinoma ETT • Gestational trophoblastic tumor with proposed origin from intermediate trophoblastic cells of the chorionic laeve • Squamoid monophasic trophoblast cells in cohesive epithelioid nests with abundant eosinophilic cytoplasm • Lacking the biphasic pattern characteristic of choriocarcinoma • Prominent cell boundaries, intracytoplasmic, and extracytoplasmic eosinophilic fibrinoid and globular material Immunoprofile CTT ETT Chorioca. Inhibin ++ ++ +/- p63 -- ++ - hCG ++ ++ +++ HPLC +/- ++ +++ Ki-67 <5% >10% >10% Teratoma, post pubertal
    [Show full text]
  • Determination of the Elongate Spermatid\P=N-\Sertolicell Ratio in Various Mammals
    Determination of the elongate spermatid\p=n-\Sertolicell ratio in various mammals L. D. Russell and R. N. Peterson Department of Physiology, School of Medicine, Southern Illinois University, Carbondale, IL 62901, U.S.A. Summary. Criteria were devised for determining the elongate spermatid\p=n-\Sertolicell ratio in various mammalian species at the electron microscope level. When data from particular species were pooled, the values were: rabbit, 12\m=.\17:1,hamster, 10\m=.\75:1; gerbil, 10\m=.\64:1;rat, 10\m=.\32:1; guinea-pig, 10\m=.\10:1;vole, 9\m=.\75:1;and monkey, 5\m=.\94:1. The elongate spermatid\p=n-\Sertolicell ratio is a measure of the workload of the Sertoli cell and is a prime factor determining their efficiency. The higher the ratio, the higher the sperm output is likely to be per given weight of seminiferous tubule parenchyma for a particular species. Introduction The number of spermatozoa provided in the ejaculate is determined by a number of factors but the major influence is the number of spermatozoa produced in the testis. In mammals that breed continuously testicular sperm production appears to be related to the size of the testis, especially the seminiferous tubule compartment. Here the kinetics of spermatogenesis dictate how many germ cells (spermatogonia) become committed to the spermatogenic process and also the time it takes these germ cells to go through various cell divisions and transformations to become a spermatozoon. The index of sperm production, or the daily sperm production, is expressed as the number of spermatozoa produced per day by the two testes of an individual, whereas the index of efficiency of sperm production is the number of spermatozoa produced per unit weight or volume of testicular tissue (Amann, 1970).
    [Show full text]
  • Jaboticabal Aspectos Morfofuncionais Das Célula
    Universidade Estadual Paulista Centro de Aqüicultura da UNESP-CAUNESP Campus - Jaboticabal Aspectos morfofuncionais das células de Sertoli de peixes teleósteos Diogo Mitsuiki Zootecnista Jaboticabal-SP Abril-2002 Universidade Estadual Paulista Centro de Aqüicultura da UNESP-CAUNESP Programa de Pós-graduação em Aqüicultura Aspectos morfofuncionais das células de Sertoli de peixes teleósteos Diogo Mitsuiki Orientadora: Profa Dra Laura Satiko Okada Nakaghi Dissertação apresentada como parte das exigências para obtenção do título de Mestre em Aqüicultura. Jaboticabal-SP Abril-2002 Agradecimentos • À Deus, por me permitir vencer mais uma etapa da minha vida. • À meus pais, pelo apoio constante as incursões que realizo na minha vida. • À meus avós, pelo apoio, pelas lições de vida e conselhos a mim passados. • À minha namorada, Satomi, por me trazer alegria, luz, paz e palavras de apoio, sempre que necessitei e me dar a satisfação de fazer parte da minha vida. • A minha orientadora, Profa Dra Laura Satiko Okada Nakaghi, pela sua orientação e lições de vida a mim dedicadas. • À Zootecnista Dra Cristina Ribeiro Dias Koberstein, conhecimento transmitidos e pelo tempo a mim dispensado. • Ao histotécnico Sr. Orandi Mateus, pelo apoio nas pesquisas realizadas no Departamento de Morfologia e Fisiologia Animal. • À banca examinadora, Prof. Dr. Carlos Alberto Vicentini e Prof. Dr Sérgio Fonseca Zaiden, pelas valiosas contribuições nesta dissertação. • Aos colegas do Departamento de Morfologia e Fisiologia Animal Atomu Furusawa, Carla Fredrichsen Moya, Wanessa Kelly Batista, Luciana Nakaghi Ganeco, Karina Ribeiro Dias e Patrícia Hoshino pela agradável convivência. i • Aos amigos de república Rafael, Tiago, Marcelo, Daniel, Edson, Marcos, Djalma e Marcel pelos momentos de diversão proporcionados em Jaboticabal.
    [Show full text]
  • EAU Guidelines on Testicular Cancer 2007
    Guidelines on Testicular Cancer P. Albers, W. Albrecht, F. Algaba, C. Bokemeyer, G. Cohn-Cedermark, A. Horwich, O. Klepp, M. P. Laguna, G. Pizzocaro © European Association of Urology 2007 TABLE OF CONTENTS PAGE 1 BACKGROUND 4 1.1 Methods 4 2 DIAGNOSIS, PATHOLOGY AND CLASSIFICATIONS 4 2.1 Scrotal ultrasound 4 2.2 Serum tumour markers 5 2.3 Inguinal exploration and orchidectomy 5 2.3.1 Organ-sparing surgery 5 2.4 Pathological examination of the testis 5 2.5 Staging and clinical classification 5 3 DIAGNOSIS AND TREATMENT OF TESTICULAR INTRAEPITHELIAL NEOPLASIA (TIN) 8 4 IMPACT ON FERTILITY AND FERTILITY-ASSOCIATED ISSUES 8 5 TREATMENT: STAGE I GERM CELL TUMOURS 9 5.1 Stage I seminoma 9 5.1.1 Adjuvant radiotherapy 9 5.1.2 Surveillance 9 5.1.3 Adjuvant chemotherapy 9 5.1.4 Retroperitoneal lymph node dissection (RPLND) 9 5.1.5 Risk-adapted treatment 10 5.1.6 Guidelines for the treatment of seminoma stage I 10 5.2 NSGCT stage I 10 5.2.1 Prognostic factors 10 5.2.2 Risk-adapted treatment 10 5.2.2.1 Surveillance 10 5.2.2.2 Adjuvant chemotherapy 10 5.2.3 Retroperitoneal lymph node dissection 11 5.3 CS1S with (persistently) elevated serum tumour markers 11 5.3.1 Guidelines for the treatment of non-seminomatous germ cell tumour (NSGCT) stage I 11 6 TREATMENT: METASTATIC GERM CELL TUMOURS 11 6.1 Stage II A/B seminoma 11 6.2 NSGCT Stage II A/B 12 6.3 Advanced metastatic disease 12 6.3.1 Primary chemotherapy 12 6.4 Restaging and further treatment 13 6.4.1 Restaging 13 6.4.2 Residual tumour resection 13 6.4.3 Consolidation chemotherapy after secondary
    [Show full text]
  • Pathology and Classification of SCLC
    cancers Review Pathology and Classification of SCLC Maria Gabriela Raso * , Neus Bota-Rabassedas and Ignacio I. Wistuba * Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; [email protected] * Correspondence: [email protected] (M.G.R.); [email protected] (I.I.W.); Tel.: +1-713-834-6026 (M.G.R.); +1-713-563-9184 (I.I.W.) Simple Summary: Small cell lung carcinoma (SCLC), is a high-grade neuroendocrine carcinoma defined by its aggressiveness, poor differentiation, and somber prognosis. This review highlights cur- rent pathological concepts including classification, immunohistochemistry features, and differential diagnosis. Additionally, we summarize the current knowledge of the immune tumor microenvi- ronment, tumor heterogeneity, and genetic variations of SCLC. Recent comprehensive genomic research has improved our understanding of the diverse biological processes that occur in this tumor type, suggesting that a new era of molecular-driven treatment decisions is finally foreseeable for SCLC patients. Abstract: Lung cancer is consistently the leading cause of cancer-related death worldwide, and it ranks as the second most frequent type of new cancer cases diagnosed in the United States, both in males and females. One subtype of lung cancer, small cell lung carcinoma (SCLC), is an aggressive, poorly differentiated, and high-grade neuroendocrine carcinoma that accounts for 13% of all lung carcinomas. SCLC is the most frequent neuroendocrine lung tumor, and it is commonly presented as an advanced stage disease in heavy smokers. Due to its clinical presentation, it is typically diagnosed in small biopsies or cytology specimens, with routine immunostaining only. However, Citation: Raso, M.G.; immunohistochemistry markers are extremely valuable in demonstrating neuroendocrine features of Bota-Rabassedas, N.; Wistuba, I.I.
    [Show full text]